Opinion

Analysis and opinion on food biotech strategy, funding, manufacturing and product development. Frameworks and scenarios are identified within each article.

People discussing a project around a laptop, a contextual photograph by Headway, not the investors described in the essay.

Opinion

Why investors pass on food biotech companies

A polite rejection is not a diagnosis. Seven questions to test against the evidence from your last fundraising conversations.

16 Oct 20269 min readOpen access

Scientist pipetting a laboratory sample, a contextual photograph by Julia Koblitz.

Opinion

Why food biotech platforms should start with an ingredient

Platforms are earned through repeatable commercial capability. A defined first ingredient makes that work concrete.

16 Oct 202612 min readOpen access